September 29, 2021

Philogen Provides Corporate Update

Philogen Provides Corporate Update Nidlegy™ and Fibromun on track with planned timelines in pivotal clinical trials Use of Nidlegy™ in non-melanoma skin cancer expanded in

Read More

ADVERTISEMENT